Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factor V (Factor V, proaccelerin, or labile factor) is a glycoprotein that plays a dual role in the blood coagulation system, acting as both a procoagulant and an anticoagulant. It is essential for thrombin generation and is regulated by activated protein C (APC). The Factor V Leiden mutation, a common cause of thrombophilia, results in resistance to APC inactivation, increasing the risk of blood clots.
Factor V is a cofactor in the prothrombinase complex, essential for thrombin generation. Activated Protein C (APC), with Protein S, degrades/inactivates Factor Va.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor V (FV).